top of page

Company Profile

President and CEO

Takuya Iwabuchi

< Social Contribution >
Visiting Professor, National Institute of Technology and Ichinoseki College of Technology
Adjunct Lecturer, Akita University Graduate School of Medicine and Engineering Science
Expert Researcher, Institute for Science, Technology and Academic Policy, the Ministry of Education, Culture, Sports, Science and Technology

< Award >

2017
2018
2020

 


2021

 


2022


2023

 

Japan Venture Award 2017 SME President's Award
Tohoku Entrepreneur Award
SMBC Startup Competition Grand Prize
Nihon Keizai Shimbun Star ☆ Atpitch Japan Resona Bank Award
Award of the Commissioner of the Japan Patent Office for Local Inventions and Achievement Award
the Ministry of Health, Labour and Welfare Appreciation Certificate Award for Antigen Test Kit Supply Business
Winner of the 9th Monozukuri Japan Grand Prize and Excellence Award

Company name

Cellspect Co., Ltd.

April 18, 2014

Establishment

Board members

President and CEO Takuya Iwabuchi
Executive director  Kazuhiro Koide
Executive officer and CTO  Wataru Hojo
Outside director  Keiji Katano

(President of Icomes Lab Co., Ltd.)
Outside director  Kinichiro Kominami

(President of Tech & FinStrategy, Inc.)

Auditor Mieko Mio(Lawyer)
Auditor Hiroshi Akasaka

Capital

1.38 billion JPY (capital reserve included)

Location

Head office 2-4-23, Kitaiioka, Morioka-shi,

Iwate, Japan​​​​​​

Employees

39 (as of March 31, 2024)

Major Shareholder   

Mizuho Capital Co., Ltd. 
Iwagin Business Creation Capital Co., Ltd.
Mitsubishi UFJ Capital Co., Ltd. 
Yakuodo Holdings Co., Ltd.            etc.

Main bank

Tohoku Bank, Ltd. / The Bank of Iwate, Ltd. / Japan Finance Corporation / Kita-Nippon Bank, Ltd.

Acquisition license/approval

License No. for type 2 medical device manufacturing & marketing business: 03B2X10003
Registration No. for medical device manufacturer: 03BZ200026
License No. for selling and leasing operations for specially-controlled medical devices: Morioka city No. 607
License No. for marketing and manufacturing of in-vitro diagnostics: 03E1X00001
Registration No. for manufacturing of in-vitro diagnostics: 03EZ200004
License No. for pharmaceuticals wholesale distribution: Iwate prefectural No. 273
Registration No. for clinical laboratory: Morioka city No. 35

Core competency

Opening up the future with biomarker sensing technology

Biomarker R&D

Infections, vaccines, oncogenes, nucleic acids, and chronic diseases

Depression/schizophrenia marker
Urinary biopyrrin

Circulating tumor cell markers

CellContact ™️

Item & system R&D

Device; sensor; probe; novel method

CTC targeting aptamer probe

CT-Capt

Gold nanoparticle nucleic acid probe

AG screen

Periodontal disease test kit

Check your mouth®

EAOC   probe

TEAS

*1

*2

*1 EAOCEndometriosis-Associated Ovarian Carcinoma (EAOC)
*2 Transvaginal Endometriosis Cyst Analysis System (TEAS)

Product service release

IVD & medical equipment
Clinical testing services
Health tech items

Packaged test service

Packaged test service.png
Neoplasia liquid tm.png

Ready to Use Reagent

IVD drugs

 Policy

Business strategy

One-stop release of multiple products and services from a single biomarker
Make full use of the latest biosensing technology !
Shifting from the clinical market to the health tech market !

bottom of page